FS KKR Capital Corp
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
Part I—FINANCIAL INFORMATION
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Investments, at fair value | ||
| Non-controlled/unaffiliated investments (amortized cost—$11,078 and 12,566, respectively) | $10,568 | $12,026 |
| Non-controlled/affiliated investments (amortized cost—$868 and $575, respectively) | 745 | 443 |
| Controlled/affiliated investments (amortized cost—$3,474 and $3,173, respectively) | 3,336 | 2,908 |
| Total investments, at fair value (amortized cost—$15,420 and $16,314, respectively) | 14,649 | 15,377 |
| Cash | 223 | 248 |
| Foreign currency, at fair value (cost—$8 and $3, respectively) | 8 | 3 |
| Receivable for investments sold and repaid | 246 | 212 |
| Income receivable | 290 | 227 |
| Unrealized appreciation on foreign currency forward contracts | 13 | 25 |
| Deferred financing costs | 32 | 23 |
| Prepaid expenses and other assets | 8 | 9 |
| Total assets | $15,469 | $16,124 |
| Liabilities | ||
| Payable for investments purchased | $— | $14 |
| Debt (net of deferred financing costs and discount of $36 and $37, respectively)(1) | 8,187 | 8,694 |
| Unrealized depreciation on foreign currency forward contracts | 4 | 1 |
| Stockholder distributions payable | 196 | 192 |
| Management and investment adviser fees payable | 56 | 59 |
| Subordinated income incentive fees payable(2) | 41 | 27 |
| Administrative services expense payable | 5 | 6 |
| Interest payable | 98 | 90 |
| Other accrued expenses and liabilities | 33 | 29 |
| Total liabilities | 8,620 | 9,112 |
| Commitments and contingencies(3) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.001 par value, 50,000,000 shares authorized, none issued and outstanding | — | — |
| Common stock, $0.001 par value, 750,000,000 shares authorized, 280,066,433 and 281,731,750 shares issued and outstanding, respectively | 0 | 0 |
| Capital in excess of par value | 9,437 | 9,610 |
| Retained earnings (accumulated deficit)(4) | (2,588) | (2,598) |
| Total stockholders’ equity | 6,849 | 7,012 |
| Total liabilities and stockholders’ equity | $15,469 | $16,124 |
| Net asset value per share of common stock at year end | $24.46 | $24.89 |
(1)See Note 9 for a discussion of the Company’s financing arrangements.
(2)See Note 2 and 4 for a discussion of the methodology employed by the Company in calculating the subordinated income incentive fees.
(3)See Note 10 for a discussion of the Company's commitments and contingencies.
(4)See Note 5 for a discussion of the sources of distributions paid by the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.